Inquiry Basket
Advances in siRNA Drug Research
Review: Drug delivery systems for RNA therapeutics
mRNA vaccine expected to prevent diseases caused by ticks
Vutrisiran, The World's Fourth RNAi Therapy, Is About to Submit A Marketing Application
From COVID-19 Vaccines to Anti-Cancer Drugs, What Is the Prospect of mRNA Therapy?
Will the mRNA vaccine become the "savior" of COVID-19?
mRNA-1647，the first infectious disease mRNA vaccine to enter the second phase of research
First RNAi treatment for inherited rare diseases
bioRxiv.: Scientists Find siRNA drugs that may inhibit SARS-CoV-2
Cell Immunity: SARS-CoV-2 vaccines status
Onpattro, The First RNAi-based therapeutic Drug
SARS-CoV-2 is undergoing mutations. Does the vaccine still work?
Application of LC-MS in the Bioassay of Oligonucleotide Drugs
GalNAc Technology for Oligonucleotide Drug Delivery
Therapeutic siRNA: Recent Advances and Prospects
Lipids Used in COVID-19 mRNA Vaccines
Vaccine Adjuvants-CpG Oligonucleotides (CpG ODN)
First LNP-mRNA In Vivo Gene Editing Therapy Reports Positive Data
First mRNA RSV Vaccine Approved for Market Release
Bridge RNA: Third-Generation Gene Editing Tool on the Horizon
Global Influenza Vaccine Market Report: Nucleic Acid Vaccines Become Mainstream
Opus Genetics Eye Gene Therapy Receives FDA Rare Pediatric Disease Designation
miRNA -The 2024 Nobel Prize in Physiology or Medicine Announcement
Global Supplier of High-Quality RNA / DNA Products & Services.
